Barclays Downgrades NVO to Equalweight (from Overweight), PT Cut to DKK 375 (from DKK 700)

via http://overnightstocks.com

• Notes company-specific concerns after FY25 profit warning

• Cites unresolved GLP-1 headwinds, pipeline challenges, CEO transition

• Obesity market remains bullish long term, but outlook for Novo more uncertain short term

$NOVO B (+1,26 %)
$NVO (+0,66 %)